Shyam S Chauhan Selected Research

Heterogeneous-Nuclear Ribonucleoprotein D

5/2022

Evaluation of Heterogeneous Nuclear Ribonucleoprotein D Expression as a Diagnostic Marker for Oral Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shyam S Chauhan Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 06/2002
4	Breast Neoplasms (Breast Cancer) 02/2021 - 01/2018
4	Neoplasm Metastasis (Metastasis) 07/2019 - 12/2003
4	Carcinoma (Carcinomatosis) 01/2019 - 04/2010
4	Glioblastoma (Glioblastoma Multiforme) 06/2016 - 04/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 08/2012
3	Squamous Cell Carcinoma of Head and Neck 05/2022 - 02/2021
3	Carcinogenesis 12/2021 - 09/2010
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 12/2010
3	Pathologic Processes 03/2014 - 06/2002
2	Glioma (Gliomas) 01/2022 - 01/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2019 - 07/2019
2	Esophageal Squamous Cell Carcinoma 01/2014 - 01/2013
2	Inflammation (Inflammations) 09/2011 - 01/2009
1	Fibrosis (Cirrhosis) 03/2022
1	Sarcopenia 03/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Thalassemia 01/2022
1	Persistent Infection 02/2021
1	Periodontitis 01/2021
1	Periodontal Diseases (Periodontal Disease) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Chronic Periodontitis 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Microsatellite Instability 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 07/2019
1	Liver Diseases (Liver Disease) 06/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2017
1	Cardiomyopathies (Cardiomyopathy) 04/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2016
1	Chronic Pancreatitis 12/2014
1	Spontaneous Abortion (Miscarriage) 11/2011
1	Blast Crisis (Blast Phase) 10/2011
1	Pain (Aches) 09/2011
1	Infections 03/2007

Drug/Important Bio-Agent (IBA)

11	Cathepsin LIBA 01/2018 - 06/2002
7	Peptide Hydrolases (Proteases)FDA Link 08/2013 - 02/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2020 - 05/2011
4	CathepsinsIBA 01/2019 - 12/2010
4	Cysteine Proteases (Cysteine Protease)IBA 01/2018 - 12/2003
3	Cysteine (L-Cysteine)FDA Link 01/2021 - 04/2017
3	Cisplatin (Platino)FDA LinkGeneric 07/2019 - 11/2006
3	Cathepsin BIBA 01/2019 - 12/2010
3	dipeptidyl peptidase IIIIBA 06/2016 - 04/2010
2	NexusIBA 12/2021 - 02/2021
2	Transcription Factors (Transcription Factor)IBA 02/2021 - 03/2014
2	CytokinesIBA 02/2021 - 03/2014
2	CateninsIBA 07/2019 - 07/2019
2	EnzymesIBA 07/2019 - 08/2013
2	DNA (Deoxyribonucleic Acid)IBA 06/2016 - 03/2015
2	Complementary DNA (cDNA)IBA 01/2014 - 01/2013
1	Heterogeneous-Nuclear Ribonucleoprotein DIBA 05/2022
1	TOR Serine-Threonine KinasesIBA 03/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	3-hydroxyphenyltrimethylammoniumIBA 01/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2022
1	serum P-component (CIt)IBA 12/2021
1	L-SelectinIBA 02/2021
1	daidzeinIBA 02/2021
1	IsoflavonesIBA 02/2021
1	RNA (Ribonucleic Acid)IBA 02/2021
1	Phenobarbital (Luminal)FDA Link 02/2021
1	MetallothioneinIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	GlucocorticoidsIBA 01/2021
1	AntigensIBA 01/2020
1	O- (5- O- (4- coumaroyl)- alpha- arabinofuranosyl)- (1- 3)- O- beta- xylopyranosyl- (1- 4)- xylopyranoseIBA 01/2020
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 07/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2019
1	A-Form DNA (A-DNA)IBA 07/2019
1	Biological ProductsIBA 01/2018
1	BilirubinIBA 06/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2017
1	Cell-Free Nucleic AcidsIBA 03/2015
1	Circulating Tumor DNAIBA 03/2015
1	ChromatinIBA 03/2014
1	AminopeptidasesIBA 03/2014
1	Interleukin-6 (Interleukin 6)IBA 03/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2014
1	MAP Kinase Kinase Kinase 3IBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 08/2013
1	Peptides (Polypeptides)IBA 08/2012
1	Phosphotransferases (Kinase)IBA 08/2012
1	TransferasesIBA 11/2011
1	Histones (Histone)IBA 11/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2011
1	Metalloproteases (Metalloproteinases)IBA 04/2010
1	CarcinogensIBA 01/2009
1	ProteomeIBA 01/2009
1	Chemokine ReceptorsIBA 03/2007

Therapy/Procedure

2	Therapeutics 12/2021 - 02/2021
1	Nephrectomy 03/2022
1	Immunotherapy 02/2021
1	Drug Therapy (Chemotherapy) 01/2021